These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2799308)

  • 21. Lymphocyte proliferative responses to bacterial antigens in B27-associated arthropathies.
    Sheldon PJ; Pell PA
    Br J Rheumatol; 1985 Feb; 24(1):11-8. PubMed ID: 3919798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further observations upon HLA-B27, Yersinia enterocolitica, and ankylosing spondylitis.
    Pease PE; Balmer SE; Tallack JE; Chahal H; Ibbotson J; Bartlett LR; Lane M; Allan RN
    Ann Rheum Dis; 1986 Jun; 45(6):526-8. PubMed ID: 3488038
    [No Abstract]   [Full Text] [Related]  

  • 23. Absence of cross-reaction between HLA B27 and yersinia enterocolitica or chlamydia trachomatis in reactive arthritis and ankylosing spondylitis.
    Roudier J; De Montclos H; Thouvenot D; Chomel JJ; Guillermet FN; Betuel H
    Clin Rheumatol; 1985 Dec; 4(4):487. PubMed ID: 3879474
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of MHC class II molecules on human monocytes is regulated independently from each other after phagocytosis of bacteria.
    Wuorela M; Jalkanen S; Toivanen P; Granfors K
    Scand J Immunol; 1996 Jan; 43(1):39-46. PubMed ID: 8560195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mimicry in Reiter's syndrome: cytotoxicity and ELISA studies of HLA-microbial relationships.
    Inman RD; Chiu B; Johnston ME; Falk J
    Immunology; 1986 Jul; 58(3):501-6. PubMed ID: 3488263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome.
    Aaron S
    Arthritis Rheum; 1985 Apr; 28(4):478-9. PubMed ID: 3872667
    [No Abstract]   [Full Text] [Related]  

  • 27. Reactive arthritis: recent advances and clinical manifestations.
    Kobayashi S; Kida I
    Intern Med; 2005 May; 44(5):408-12. PubMed ID: 15942084
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenetic and microbial factors in acute anterior uveitis.
    Careless DJ; Chiu B; Rabinovitch T; Wade J; Inman RD
    J Rheumatol; 1997 Jan; 24(1):102-8. PubMed ID: 9002019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Yersinia arthritis. Long-term follow up].
    Herrlinger JD; Asmussen JU
    Z Rheumatol; 1993; 52(4):210-4. PubMed ID: 8212919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yersinia antibodies in inflammatory joint diseases.
    Granfors K; Isomäki H; von Essen R; Maatela J; Kalliomäki JL; Toivanen A
    Clin Exp Rheumatol; 1983; 1(3):215-8. PubMed ID: 6335856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia.
    van Bohemen CG; Grumet FC; Zanen HC
    Immunology; 1984 Aug; 52(4):607-10. PubMed ID: 6378768
    [No Abstract]   [Full Text] [Related]  

  • 32. Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis.
    Lahesmaa-Rantala R; Lehtonen OP; Granfors K; Toivanen A
    Arthritis Rheum; 1987 Oct; 30(10):1176-81. PubMed ID: 3675663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of IgG class antibodies to recombinant HSP60 kDa of Yersinia enterocolitica in sera of patients with uveitis.
    Cancino-Diaz JC; Vargas-Rodríguez L; Grinberg-Zylberbaum N; Reyes-López MA; Domínguez-López ML; Pablo-Velazquez A; Cancino-Diaz ME
    Br J Ophthalmol; 2004 Feb; 88(2):247-50. PubMed ID: 14736785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity.
    Mertz AK; Daser A; Skurnik M; Wiesmüller KH; Braun J; Appel H; Batsford S; Wu P; Distler A; Sieper J
    Mol Med; 1994 Nov; 1(1):44-55. PubMed ID: 8790600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gram-negative bacteria, HLA-B27 and inflammatory bowel disease.
    Pease PE; Lane MR; Chahal H; Tallack JE; Allan RN
    Br J Rheumatol; 1988; 27 Suppl 2():29-31. PubMed ID: 3261188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive arthritis triggered by Yersinia enterocolitica: a review of 18 pediatric cases.
    Taccetti G; Trapani S; Ermini M; Falcini F
    Clin Exp Rheumatol; 1994; 12(6):681-4. PubMed ID: 7895406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The results of the dynamic observation of patients with reactive Yersinia arthritis].
    Ivanova MM; Akimova TF; Inina LI; Iushchenko GV; Izomiaki Kh; Lechtinen K; Granfors K
    Ter Arkh; 1991; 63(5):18-20. PubMed ID: 1887403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of circulating Yersinia-specific immune complexes in patients with yersiniosis.
    Lahesmaa-Rantala R; Granfors K; Lehtonen OP; Toivanen A
    Clin Immunol Immunopathol; 1987 Feb; 42(2):202-10. PubMed ID: 2948750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?
    Ringrose JH
    Ann Rheum Dis; 1999 Oct; 58(10):598-610. PubMed ID: 10491358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.
    Merilahti-Palo R; Söderström KO; Lahesmaa-Rantala R; Granfors K; Toivanen A
    Ann Rheum Dis; 1991 Feb; 50(2):87-90. PubMed ID: 1998396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.